If Pfizer’s COVID-19 vaccine is added to the pediatric vaccine schedule, and if it’s mandated like other childhood vaccines, it will become an evergreen market representing billions of dollars to the drug companies.

tory at a glance:

  • Pfizer announced preliminary data from Phase 2/3 trials in children 6 months to under 5 years would be submitted to the U.S. Food and Drug Administration (FDA) for emergency use authorization; the data are based on 1,678 children and 10 who got sick, which Pfizer claims is an 80.3% effectiveness rate.
  • Even vaccine advocate Dr. Paul Offit is dismayed at the number from which Pfizer is drawing conclusions. Just days before, New York announced the vaccine efficacy in children 5 to 11 years fell to 12% within two months after vaccination.
  • Despite 48,833 records in the Vaccine Adverse Event Reporting System (VAERS) of adverse events in children under 18 from the vaccine, Pfizer says the shot for 6 months to under 5 years old has “a safety profile similar to placebo.”
  • Moderna announced their submission to the FDA for children younger than 5 years has a 37% to 51% effectiveness, which is close to the effectiveness of the flu vaccine.
  • Data from the Centers for Disease Control and Prevention (CDC) show that as the months roll by, more Americans are not taking or completing the shots to meet CDC criteria to be fully vaccinated. The push to vaccinate children may likely be related to the pharmaceutical industry’s goal to mandate the vaccine under full legal immunity from damages.

“This is the holy grail if you’re a vaccine manufacturer of a COVID vaccine right now. You want it to be fully licensed, but not put it on the market until you get it on the children’s schedule.”

The reason the pharmaceutical industry is pushing for vaccines in young children is clearly based on financial interests.

https://childrenshealthdefense.org/defender/covid-vaccine-pediatric-immunization-schedule-cola/?